17.9 C
New York
Wednesday, June 3, 2026

Tag: solid

Zhihu Inc. Reports Unaudited First Quarter 2026 Financial Results

BEIJING, China, June 03, 2026 (GLOBE NEWSWIRE) -- Zhihu Inc. (“Zhihu” or the “Company”) (NYSE: ZH; HKEX: 2390), a leading online content community in China, today announced its unaudited financial results for the quarter ended March 31, 2026.

SKHTU Builds US-EU Compliance System, Advancing Global Digital Finance Expansion

DENVER, June 03, 2026 (GLOBE NEWSWIRE) -- The crypto industry is undergoing a shift from “regulation chasing innovation” to “regulation driving innovation.” SKHTU Exchange recently released global compliance strategy that is a reflection of this trend. The focus is on leveraging dual US MSB and SEC licenses, while coordinating with the European MiCA regulatory framework. This approach marks the SKHTU establishment of a cross-system compliance loop within the international regulatory landscape, providing institutional safeguards for global operations.

Statkraft og Elkem inngår syvårig kraftavtale for Bjølvefossen-verket på Vestlandet

(Oslo, 3. juni 2026) Statkraft og Elkem ASA har inngått en ny langsiktig kraftavtale som sikrer konkurransedyktig og forutsigbar krafttilgang til Elkems verk på Bjølvefossen, i Kvam kommune i Vestland. Avtalen gjelder for perioden 2031–2037 og sikrer levering av totalt 1 534 GWh til verket. 

Antengene to Present First Preclinical Data on ATG-207 (αCD3-TGF-β Bifunctional Fusion Protein) at EULAR 2026

SHANGHAI and HONG KONG, June 3, 2026 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK) , a leading innovative, commercial-stage global biotech company dedicated...

Kelun-Biotech Presents First-in-human Study Data for Its Novel B7-H3 ADC SKB500 at ASCO 2026

CHENGDU, China, June 3, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) announced that at the 2026 American Society...

Crescent Biopharma to Present at June Investor Conferences

WALTHAM, Mass., June 02, 2026 (GLOBE NEWSWIRE) -- Crescent Biopharma, Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing the next wave of therapies for cancer patients, today announced that management is scheduled to present at the following investor conferences in June:

Cocamidopropyl Betaine (CAPB) Market Size to Reach USD 1.45 Billion by 2033, Driven by Growing Demand for Mild Surfactant Systems, Regulatory-Aligned Formulations, and Expanding...

Verified Market Research® Reports Rising Adoption Across Personal Care, Household Cleaning, Industrial Cleaning, and Agrochemical Formulations as Manufacturers Prioritize Foam Stability, Cleansing Performance, Formulation...

Cocamidopropyl Betaine (CAPB) Market Size to Reach USD 1.45 Billion by 2033, Driven by Growing Demand for Mild Surfactant Systems, Regulatory-Aligned Formulations, and Expanding...

Verified Market Research® Reports Rising Adoption Across Personal Care, Household Cleaning, Industrial Cleaning, and Agrochemical Formulations as Manufacturers Prioritize Foam Stability, Cleansing Performance, Formulation...

Heron Power Collaborates with LG Energy Solution Vertech, Uniting American-Made Battery Energy Storage Systems and Solid State Transformers to Power the Modern Grid

Heron Power, a U.S.-based manufacturer of next-generation medium-voltage power electronics, today announced a collaboration with LG Energy Solution Vertech

Ampace Redefines UPS Battery Role in AI Data Centers at Datacloud Global Congress 2026

CANNES, France, June 2, 2026 /PRNewswire/ -- Ampace is exhibiting at Datacloud Global Congress 2026 (Booth 301, Palais -1 Hall, Cannes) this week, presenting...

Cumberland Pharmaceuticals and Vanderbilt Health Announce Potential New Therapy to Prevent Cancer Metastasis

Positive Results from Phase 2a Clinical TrialStudy met its primary endpoint demonstrating safety and tolerability of ifetroban in patients with high-risk solid tumorsTrial revealed promising...

Landsvirkjun’s first quarter results

Solid operations and strong position in the first quarter

Kazia Therapeutics Appoints James Levine as Chief Financial Officer

SYDNEY, June 2, 2026 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA) ("Kazia," "Kazia Therapeutics" or the "Company"), a clinical-stage oncology company advancing therapies designed...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsSolid